Answers are grounded in this paper and cite their sources.
Review finds traditional Chinese medicine modulates epithelial-mesenchymal transition and anoikis in cancer, suggesting new treatment insights.
Tumour metastasis is a significant factor that threatens human health and life. Current research has shown that Traditional Chinese Medicine (TCM) can inhibit epithelial-mesenchymal transition (EMT) and restore the sensitivity of tumour cells to anoikis by influencing tumour metabolism, the extracellular matrix, transcription factors, related signalling pathways, and non-coding RNA. This review summarises 46 types of TCM (including single herb extracts, compounds, and formulations) that may reduce tumour recurrence and metastasis rates in cancer treatment. The findings indicate that TCM regulates EMT and anoikis processes by modulating the Wnt/β-catenin, TGF-β, and PI3K/AKT signalling pathways, thereby affecting the extracellular matrix, apoptosis, and metabolic reprogramming. TCM targets molecular mechanisms to construct signal pathway networks to regulate EMT and anoikis, ultimately achieving the inhibition of tumour metastasis. This discovery provides new insights for the application of TCM in future cancer treatment.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: